Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Bruker Announced A Minority Investment In NovAliX, A Preclinical Contract Research Organization Specializing In Drug Discovery Services, Financial Details Of The Investment Were Not Disclosed

Author: Benzinga Newsdesk | August 07, 2024 07:18am

The minority investment aims to accelerate the growth and further expansion of NovAliX, particularly within Europe and the United States.

Posted In: BRKR